Alternatives to Acrivon AB
Acrivon AB is a AI Tools & Apps tool: acrivon AB develops targeted therapies for cancer patients by matching drug mechanisms to the biologic drivers of cancer using their proprietary AP3 platform. Here are the 60 closest alternatives, compared on pricing, features and what real users say.
Acrivon AB profileOpen source alternatives (5)More AI Tools & Apps alternatives
The 20 closest AI Tools & Apps companies to Acrivon AB
- Website
Insilico Medicine24BiotechHong Kong, ChinaA clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.
- EXExscientia2HealthcareOxford, United Kingdom
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
- Website
Sinopia Biosciences54BiotechnologySan Diego, USA$2.2MBiotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
Warp56AI Tools & AppsSan Francisco, United States$60.0MWarp is an open platform for building software with agents. Build cloud software factories with Oz, and build locally with Warp’s open source agentic terminal. Free to start.
- Website
Denali Therapeutics70BiotechSouth San Francisco, United States$1.0BBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
- Website
Immunai69HealthcareNew York, United States$295.0MMapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.
- Website
Isomorphic Labs68Drug DiscoveryLondon, United Kingdom$4.7BAI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.
- Website
Manifold Bio63BiotechBoston, United States$118.0MAI-guided drug discovery platform for tissue-targeted medicines.
- Website
Somite.ai63Life SciencesTel Aviv, Israel$57.1MAI-driven digital twin of embryo development for cell-based therapies.
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
VILYA62BIO + LIFE SCIENCESSan Francisco, United States$121.0MAI-powered platform for designing novel molecular structures for new medicines.
- Website
Cue Biopharma, .62BiotechBoston, United States$10.0MDeveloping engineered biologics to harness the immune system for disease treatment.
- Website
Elicit62Artificial IntelligenceOakland, United States$31.0MAI-powered research assistant for scientific literature review and data extraction.
- Website
QSimulate61Drug DiscoveryBoston, United States$13.5MLeveraging quantum mechanics for accelerated molecular simulations in drug discovery.
- Website
Upstream Bio61Life SciencesWaltham, United States$400.0MClinical-stage biotech developing a monoclonal antibody targeting TSLP for inflammatory diseases.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Atomwise60Drug DiscoverySan Francisco, United States$176.3MAtomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.
Showing the 20 closest matches. See the rest on the Acrivon AB profile.
Compare Acrivon AB head to head
Side by side on what each one does, what it costs, and what real users report.